Testing times for diagnostics firm UGenix as Covid demand drops
The medical technology company is looking to list in Hong Kong after a windfall from Covid testing, but its other screening services are not yet lucrative Key Takeaways: Covid tests…
Recent Articles
RELATED ARTICLES
-
Kindstar Globalgene finds bargain in solid tumor testing acquisition
9960.HK -
Sinking Burning Rock faces de-listing. But could privatization bid come first?
BNR.US
-
So-Young dolls up with pivot to high-end services
SY.US
- Baiwang eyes Hong Kong IPO to support its money-hungry loan facilitation business
- Payment app Lianlian seeks IPO relief from cash crunch
- Lesi Group underwhelms with IPO in crowded online ad market
- Voicecomm talks up its prospects on big potential for conversational AI
